Sublingual flagellin protects against acute pneumococcal pneumonia in a TLR5-dependent and NLRC4-independent fashion.

Résumé : AIM: To evaluate efficacy of sublingual flagellin to treat acute pneumonia. MATERIALS & METHODS: Mice were treated sublingually with flagellin and challenged intranasally with a lethal dose of pneumococcus. Flagellins lacking TLR5 or NLRC4 activation domains were used to assess their contribution to protection. RESULTS: Sublingual flagellin protected mice in a TLR5-dependent, NLRC4-independent fashion. Neutrophils were required for protection. Flagellin-stimulated lung epithelial cells recapitulated the lung's transcriptional profile suggesting they could be targeted by flagellin in vivo. CONCLUSION: Ligation of TLR5, a pathogen recognition receptor not naturally engaged by pneumococcus, protects mice from invasive pneumonia when administered via sublingual route. This can be a highly cost-effective alternative therapy against pneumonia.
Type de document :
Article dans une revue
Future Microbiology, Future Medicine, 2016, 11 (9), pp.1167-77
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-01529275
Contributeur : Jean-Claude Sirard <>
Soumis le : mardi 30 mai 2017 - 14:38:41
Dernière modification le : lundi 5 février 2018 - 15:22:12

Identifiants

  • HAL Id : inserm-01529275, version 1
  • PUBMED : 27546231

Collections

Citation

Natalia Muñoz-Wolf, Analía Rial, Delphine Fougeron, Julien Tabareau, Jean-Claude Sirard, et al.. Sublingual flagellin protects against acute pneumococcal pneumonia in a TLR5-dependent and NLRC4-independent fashion.. Future Microbiology, Future Medicine, 2016, 11 (9), pp.1167-77. 〈inserm-01529275〉

Partager

Métriques

Consultations de la notice

23